[Effects of specific radioactivities and cholagogues on tissue distribution of 131I-6 beta-iodomethyl-19-norcholest-5(10)-en-3 beta-ol(NCL-6-131I) in rats].
作者信息
Ito T, Ogawa H, Maeda M, Kojima M
出版信息
Yakugaku Zasshi. 1983 Jun;103(6):644-9.
PMID:6655551
Abstract
摘要
相似文献
1
[Effects of specific radioactivities and cholagogues on tissue distribution of 131I-6 beta-iodomethyl-19-norcholest-5(10)-en-3 beta-ol(NCL-6-131I) in rats].
Yakugaku Zasshi. 1983 Jun;103(6):644-9.
2
3
Radiation dosimetry of adrenal imaging agents 19-iodocholesterol and 6-iodomethylnorcholesterol.
Int J Appl Radiat Isot. 1978 May;29(4-5):277-9. doi: 10.1016/0020-708x(78)90055-8.
4
[Clinical values of adrenal scintigraphy by I-6-beta-iodomethyl-19-norcholesterol (123I-NCL) (author's transl)].
Kaku Igaku. 1982 Mar;19(2):245-53.
5
A comparison of 19-iodocholesterol-131I with 6beta-iodomethyl-19-norcholest-5(10)-en-3beta-ol-131I as an adrenal-scanning agent.
Chem Pharm Bull (Tokyo). 1976 Oct;24(10):2322-6. doi: 10.1248/cpb.24.2322.
6
Enterohepatic circulation and distribution of 131I-6 beta-iodomethyl-19-norcholesterol (NP-59).
Nucl Med Commun. 1986 Aug;7(8):625-30. doi: 10.1097/00006231-198608000-00009.
7
[Use of pharmacological preparations for the purpose of improving the visualization of the adrenals with 19-iodocholesterol-131I].
Med Radiol (Mosk). 1979 Jan;24(1):37-41.
8
New adrenal-scanning agent.
J Nucl Med. 1975 Jul;16(7):666-8.
9
[Adrenal scintigraphy with 131I-6beta-iodomethyl-19-norcholesterol: good practice guideline].
Ann Endocrinol (Paris). 1998 Nov;59(4):344-53.
10
3-Ethyl and 3-methyl ethers of 19-iodocholesterol as potential adrenal scanning agents.
Steroids. 1981 Feb;37(2):133-41. doi: 10.1016/s0039-128x(81)80013-x.
Zotero 插件